Greg Petersen - 08 May 2024 Form 4 Insider Report for PLUS THERAPEUTICS, INC. (PSTV)

Reporting relationship: Director
Issuer ticker: PSTV
Reported as of: 08 May 2024
Net transaction value: +$25,000
SEC form: 4
Accepted by SEC: 10 May 2024, 07:30:14 UTC
Prior SEC filing: 26 Feb 2024
Next SEC filing: 15 May 2024
Source filing: View source filing
Reporting owner signature: /s/ Andrew Sims, attorney-in-fact

Key filing fact

Greg Petersen filed Form 4 for PLUS THERAPEUTICS, INC. (PSTV) on 10 May 2024.

Key facts

This page summarizes Greg Petersen's Form 4 filing for PLUS THERAPEUTICS, INC. (PSTV).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 10 May 2024, 07:30.

Change

Previous filing in this sequence was filed on 26 Feb 2024.
Current net transaction value: +$25,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PSTV transaction

Common Stock

Purchase

Transaction value: $25,000
Shares: +12,255
Change %: +51%
Price: $2.04
Shares after: 36,421
Date: 08 May 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PSTV transaction Derivative

Warrants (Right to buy)

Award

Transaction value: $0
Shares: +24,510
Change %
Price: $0.000000
Shares after: 24,510
Date: 08 May 2024
Ownership: Direct
Underlying class: Common Stock Warrants
Underlying amount: 24,510
Exercise price: $1.79
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The expiration date for 12,255 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 12,255 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants.

Footnote F2

Half of the warrants are Series A warrants and the other half are Series B warrants.